Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.

COPD and Sudden Cardiac Death Risk

Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and the condition might also raise a patient's odds for sudden cardiac death.

First Breath-Actuated, Dry-Powder Inhaler for Asthma

Teva announced that the FDA has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.

No Connection Between Clean House, Asthma

Despite the widely accepted assumption that the rise in allergic disorders may be due to improved hygiene, a new study has found no connection between development of allergies and asthma and personal hygiene or home cleanliness.

For Acute LRTI: Azithromycin or Amoxicillin?

In a new review published in the Cochrane Library, researchers sought to compare the effectiveness of the macrolide antibiotic azithromycin to the broad-spectrum penicillin amoxicillin or amoxicillin/clavulanic acid (broad-spectrum penicillin + beta-lactamase inhibitor) for the treatment of lower respiratory tract infections.

E-Cigarettes Could Up Respiratory Infection Risk

Vapor from electronic cigarettes may increase young people's risk of respiratory infections, regardless of whether or not it contains nicotine.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

Asthma Treatments: Inhalations

Review this updated chart on inhalations for asthma treatment for quick information when you need it.

News

Statin Use Before, After Cancer Diagnosis Linked to Improved Survival

Use of statins for a year before a diagnosis of lung cancer is associated with a 12% lower risk of cancer-specific mortality, new research suggests.

Breo Ellipta Inhaler Gains Expanded Indication

The Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged 18 years and older.

First Codeine-Based Ext-Rel Cough Suspension Approved

Vernalis and Tris Pharma announced that the Food and Drug Administration (FDA) has approved Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension.

3-D Printed Implant Successfully Treats Tracheobrochomalacia

An implant created with a three-dimensional (3-D) printer has demonstrated success in three patients, from 3 to 16 months old, with tracheobronchomalacia.

Featured courses from mycme

ACP: Regulate E-Cigarettes, Ban FlavoringsExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Vaccine Prevents Pneumonia Among SeniorsExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Achieving and Sustaining Asthma Control in the Community SettingExternal web site

In this activity, experts will review the role of inflammation in both the large and ...

CME|CPE|CE 1.50 Credits

Sign Up for Free e-newsletters